Symphogen is Biotechnology in Denmark that focus on recombinant polyclonal antibodies business. Founded in 2000. They cover business area such as developer, recombinant polyclonal antibody, infectious disease, cancer, idiopathic thrombocytopenic purpura, hemolytic disease, newborn, recombinant polyclonal anti-vaccine virus, smallpox vaccination, treatment, a high likelihood.
2000
( 24 years old in 2024 )
Recombinant Polyclonal Antibodies
-
Pederstrupvej 93
2750 Ballerup
Denmark
Private
developerrecombinant polyclonal antibodyinfectious diseasecanceridiopathic thrombocytopenic purpurahemolytic diseasenewbornrecombinant polyclonal anti-vaccine virussmallpox vaccinationtreatmenta high likelihood
* We use standard office opening hours in near Symphogen's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Symphogen is Biotechnology business from Denmark that founded in 2000 (24 years old in 2024), Symphogen business is focusing on Recombinant Polyclonal Antibodies.
Symphogen headquarter office and corporate office address is located in Pederstrupvej 93 2750 Ballerup Denmark.
Symphogen was founded in Denmark.
In 2024, Symphogen is currently focus on recombinant polyclonal antibodies sector.
Above is snippet of Google Trends for "recombinant polyclonal antibodies" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Symphogen, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
